A GnRH-antagonist made by Serono. Approved for women undergoing in vitro fertilisation), with good results when started on day 7 of the cycle, after 5 or 6 days' Gonal-F in suppressing the LH surge; the dosage, however, appears to be critical, to avoid over-suppressing natural luteinising hormone. Marketed as Cetrotide.